<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: cells</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Doctors question Perry's stem cell back treatment</title>
   	 <description>(AP) -- He calls it innovative. Others call it a big risk. In any case, the stem cell procedure that Texas Gov. Rick Perry had last month was an unusual experiment to fix a common malady: a bad back.</description>
	  <link>http://medicalxpress.com/news/2011-08-doctors-perry-stem-cell-treatment.html</link>
	 <category>Other</category>
	 <pubDate>Fri, 19 Aug 2011 03:50:40 EST</pubDate>
	 <guid isPermaLink="false">news232944624</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/doctorsquest.jpg" width="90" height="90" />
</item>
<item>
     <title>Confirmation that vitamin D acts as a protective agent against the advance of colon cancer</title>
   	 <description>The indication that vitamin D and its derivatives have a protective effect against various types of cancer is not new. In the field of colon cancer, numerous experimental and epidemiological studies show that vitamin D3 (or cholecalciferol) and some of its derivatives inhibit the growth of cancerous cells. Researchers at the Vall d'Hebron Institute of Oncology (VHIO), in collaboration with the Alberto Sols Institute of Biomedical Research (CSIC-UAB), have confirmed the pivotal role of vitamin D, specifically its receptor (VDR), in slowing down the action of a key protein in the carcinogenic transformation process of colon cancer cells. These results are being published in the journal PLoS One.</description>
	  <link>http://medicalxpress.com/news/2011-08-vitamin-d-agent-advance-colon.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 16 Aug 2011 09:17:00 EST</pubDate>
	 <guid isPermaLink="false">news232705003</guid>
	 
</item>
<item>
     <title>New strategy to attack tumor-feeding blood vessels</title>
   	 <description>Scientists at the Walter and Eliza Hall Institute have discovered a key molecule needed to kill the blood vessels that supply tumours.</description>
	  <link>http://medicalxpress.com/news/2011-06-strategy-tumor-feeding-blood-vessels.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 06 Jun 2011 10:02:20 EST</pubDate>
	 <guid isPermaLink="false">news226573325</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/newstrategyt.jpg" width="90" height="90" />
</item>
<item>
     <title>'Fasting pathway' points the way to new class of diabetes drugs</title>
   	 <description>A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease.</description>
	  <link>http://medicalxpress.com/news/2011-05-fasting-pathway-class-diabetes-drugs.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 12 May 2011 12:25:32 EST</pubDate>
	 <guid isPermaLink="false">news224421912</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/fastingpathw.jpg" width="90" height="85" />
</item>


</channel>
</rss>
